Recombinant NKG2A (Monalizumab Biosimilar) antibody

Catalog No. ABIN7666416

The Human Monoclonal anti-NKG2A (Monalizumab Biosimilar) antibody has been validated for . It is suitable to detect NKG2A (Monalizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant NKG2A (Monalizumab Biosimilar) antibody (ABIN7666416)

Target: NKG2A (Monalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This NKG2A (Monalizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Product Details anti-NKG2A (Monalizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: NKG2A antibody (Monalizumab biosimilar)

Purity: ≥95 % (SDS-PAGE&SEC)

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Storage Comment: Please store the product under the recommended conditions in the the instructions.

Target Details for NKG2A (Monalizumab Biosimilar)

Target: NKG2A (Monalizumab Biosimilar)

Alternative Name: Monalizumab biosimilar

Target Type: Biosimilar

Background: Monalizumab | KLRC1

Gene ID: 3821

UniProt: P26715